Freedom Capital Markets Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $31

Freedom Capital Markets has initiated coverage on Doximity (NYSE: DOCS) with a Buy rating. The analyst, Gene Mannheimer, has set a price target of $31 for the stock.